|
|
REGULATION OF SKELETAL MUSCLE DEVELOPMENT AND MAINTENANCE BY PROTEIN O-GLUCOSYLTRANSFERASE 1 (POGLUT1) |
| 1 R01 AR076770-01A1 |
JAFAR-NEJAD, HAMED |
NIAMS |
2020 |
|
|
Drug-eluting joint implants with synergistic antimicrobial release and risk stratified models of preclinical efficacy testing |
| 1 R01 AR077023-01 |
ORAL, EBRU |
NIAMS |
2020 |
|
|
Metabolic Biomarkers for Fibromyalgia |
| 1 R01 AR077418-01 |
SLUKA, KATHLEEN A |
NIAMS |
2020 |
|
|
Rapid Low-Cost Quantitative 3D MRI and Gait Assessment of the Knee |
| 1 R01 AR077604-01 |
HARGREAVES, BRIAN ANDREW |
NIAMS |
2020 |
|
|
Investigating the direct reprogramming of fibroblasts into skeletal muscle progenitors |
| 1 R01 AR077695-01 |
HOCHEDLINGER, KONRAD |
NIAMS |
2020 |
|
|
The Role of TRAPPC9 in Osteoclast Differentiation and Function |
| 1 R01 AR077762-01 |
SAFADI, FAYEZ F |
NIAMS |
2020 |
|
|
Multiscale models of fibrous interface mechanics |
| 1 R01 AR077793-01 |
GENIN, GUY M |
NIAMS |
2020 |
|
|
Validation of Novel Target for OA Treatment |
| 1 R01 AR077890-01 |
SAMPEN, HEE-JEONG IM |
NIAMS |
2020 |
|
|
Micrococcal nuclease-triggered antibiotics release: a prophylactic implant coating against S. aureus infections |
| 1 R01 AR078044-01 |
SONG, JIE |
NIAMS |
2020 |
|
|
Strategies for treatment of Down syndrome: Identifying age- and sex-specific developmental windows using inducible genetic reduction of Dyrk1a |
| 1 R01 AR078663-01 |
ROPER, RANDALL J |
NIAMS |
2020 |
